Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The c-MYC promoter G-quadruplex is a four-stranded DNA secondary structure formed within the nuclease hypersensitivity element III1 (NHE III1) located upstream of the P1 promoter of the c-MYC oncogene, specifically involving four consecutive guanine runs (Myc2345) in a 27-nucleotide purine-rich segment. It adopts a biologically relevant parallel-stranded intramolecular conformation with three guanine tetrads and short loops, exhibiting high stability in potassium solutions. This structure functions as a transcriptional repressor by silencing c-MYC expression, a proto-oncogene critical for cell proliferation, apoptosis, and cancer progression; its disruption via mutations increases c-MYC transcription threefold. Recent evidence also indicates a positive regulatory role, where the folded G-quadruplex recruits transcription factors like SP1 and CNBP, alters chromatin landscape including histone modifications and nucleosome occupancy, and enhances P1 promoter activity in endogenous contexts. It serves as a binding hub for multiple transcription factors, particularly at highly expressed cancer gene promoters, competing with double-stranded DNA motifs. Small molecules such as TMPyP4 bind and stabilize this G-quadruplex, suppressing c-MYC expression and downstream targets like hTERT and ODC, positioning it as a therapeutic target for anticancer agents that modulate oncogene transcription through DNA structure stabilization rather than sequence-specific interactions.
Stabilization of G-quadruplex structure to repress c-MYC transcription
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on c-MYC promoter G-quadruplex (MycG4).